Mediwound Ltd (MDWD) is not a strong buy at this time for a beginner investor with a long-term strategy. The technical indicators are bearish, the financial performance shows significant revenue decline, and there are no positive catalysts or strong trading signals to justify an immediate investment. It is better to wait for clearer signs of growth or positive momentum before considering an entry.
The technical indicators for MDWD are bearish. The MACD is negatively expanding below zero (-0.0841), the RSI is neutral at 24.052, and the moving averages indicate a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading below key support levels, with the current pre-market price of $15.71 below the pivot level of $16.712.

NULL identified. There is no recent news, no significant insider or hedge fund activity, and no recent congress trading data.
The financial performance in 2025/Q4 shows a significant revenue drop (-68.03% YoY) and a decline in gross margin (-3.69% YoY). Additionally, the bearish technical indicators and weak options sentiment further weigh against the stock.
In 2025/Q4, revenue dropped significantly by 68.03% YoY to $1,867,000. However, net income improved to -$7,183,000 (up 83.80% YoY), and EPS increased to -0.56 (up 55.56% YoY). Gross margin declined to 14.89%, down 3.69% YoY. Overall, the financials indicate weak revenue growth but some improvement in profitability metrics.
No recent analyst rating or price target changes are available for MDWD.